|
TWI491606B
(zh)
|
2009-07-13 |
2015-07-11 |
Gilead Sciences Inc |
調節細胞凋亡信號之激酶的抑制劑
|
|
EP2651417B1
(en)
|
2010-12-16 |
2016-11-30 |
Calchan Limited |
Ask1 inhibiting pyrrolopyrimidine derivatives
|
|
UY34573A
(es)
|
2012-01-27 |
2013-06-28 |
Gilead Sciences Inc |
Inhibidor de la quinasa que regula la señal de la apoptosis
|
|
WO2015081127A2
(en)
|
2013-11-26 |
2015-06-04 |
Gilead Sciences, Inc. |
Therapies for treating myeloproliferative disorders
|
|
EP3102238A1
(en)
|
2014-01-20 |
2016-12-14 |
Gilead Sciences, Inc. |
Therapies for treating cancers
|
|
US20150342943A1
(en)
*
|
2014-06-03 |
2015-12-03 |
Gilead Sciences, Inc. |
Methods of treating liver disease
|
|
TW201618781A
(zh)
|
2014-08-13 |
2016-06-01 |
吉李德科學股份有限公司 |
治療肺高血壓之方法
|
|
EP3197448B1
(en)
|
2014-09-24 |
2019-04-24 |
Gilead Sciences, Inc. |
Methods of treating liver disease
|
|
MA41252A
(fr)
*
|
2014-12-23 |
2017-10-31 |
Gilead Sciences Inc |
Formes solides d'un inhibiteur d'ask 1
|
|
TWI685491B
(zh)
*
|
2014-12-23 |
2020-02-21 |
美商基利科學股份有限公司 |
製備５-（４-環丙基-１ｈ-咪唑-１-基）-ｎ-（６-（４-異丙基-４ｈ-１,２,４-三唑-３-基）吡啶-２-基）-２-氟-４-甲基苯甲醯胺之方法
|
|
TW201639573A
(zh)
|
2015-02-03 |
2016-11-16 |
吉李德科學股份有限公司 |
有關治療癌症之合併治療
|
|
WO2016141092A1
(en)
|
2015-03-04 |
2016-09-09 |
Gilead Sciences, Inc. |
Toll-like receptor modulating 4,6-diamino-pyrido[3,2-d]pyrimidine compounds
|
|
KR101974793B1
(ko)
|
2015-07-06 |
2019-05-02 |
길리애드 사이언시즈, 인코포레이티드 |
Cot 조정제 및 그의 사용 방법
|
|
EP3355875B1
(en)
|
2015-10-01 |
2021-09-29 |
Gilead Sciences, Inc. |
Combination of a btk inhibitor and a checkpoint inhibitor for treating cancers
|
|
TW201726130A
(zh)
*
|
2015-10-02 |
2017-08-01 |
基利科學股份有限公司 |
用於治療癌症之組合療法
|
|
EP3394044A1
(en)
|
2015-12-17 |
2018-10-31 |
Gilead Sciences, Inc. |
Tank-binding kinase inhibitor compounds
|
|
AU2017228371A1
(en)
|
2016-03-04 |
2018-09-13 |
Gilead Sciences, Inc. |
Compositions and combinations of autotaxin inhibitors
|
|
AU2017248354A1
(en)
|
2016-04-08 |
2018-10-04 |
Gilead Sciences, Inc. |
Compositions and methods for treating cancer, inflammatory diseases and autoimmune diseases
|
|
CN108350082B
(zh)
|
2016-06-13 |
2021-09-24 |
天境生物科技(上海)有限公司 |
Pd-l1抗体及其用途
|
|
US20180036289A1
(en)
|
2016-08-04 |
2018-02-08 |
Gilead Sciences, Inc. |
Cobicistat for use in cancer treatments
|
|
EP3507288B1
(en)
|
2016-09-02 |
2020-08-26 |
Gilead Sciences, Inc. |
4,6-diamino-pyrido[3,2-d]pyrimidine derivaties as toll like receptor modulators
|
|
CN109923106B
(zh)
|
2016-09-02 |
2022-09-13 |
吉利德科学公司 |
toll样受体调节剂化合物
|
|
US20180133212A1
(en)
|
2016-11-03 |
2018-05-17 |
Gilead Sciences, Inc. |
Combination of a bcl-2 inhibitor and a bromodomain inhibitor for treating cancer
|
|
CA3042398A1
(en)
|
2016-11-11 |
2018-05-17 |
Gilead Sciences, Inc. |
Methods of treating liver disease
|
|
WO2018097977A1
(en)
|
2016-11-22 |
2018-05-31 |
Gilead Sciences, Inc. |
Crystalline forms of a phosphate complex of a bet inhibitor
|
|
AR110252A1
(es)
|
2016-11-30 |
2019-03-13 |
Gilead Sciences Inc |
Compuestos heterocíclicos fusionados como inhibidores de la quinasa cam
|
|
PL3572412T3
(pl)
*
|
2017-01-22 |
2021-09-27 |
Fujian Cosunter Pharmaceutical Co., Ltd. |
Pochodna pirydyny jako inhibitor ask1 oraz sposób jej wytwarzania oraz zastosowanie
|
|
CN109071448B
(zh)
*
|
2017-01-22 |
2020-03-17 |
福建广生堂药业股份有限公司 |
Ask1抑制剂及其制备方法和应用
|
|
EP3383916B1
(en)
|
2017-01-24 |
2022-02-23 |
I-Mab Biopharma US Limited |
Anti-cd73 antibodies and uses thereof
|
|
WO2018156901A1
(en)
|
2017-02-24 |
2018-08-30 |
Gilead Sciences, Inc. |
Inhibitors of bruton's tyrosine kinase
|
|
CA3054403A1
(en)
|
2017-02-24 |
2018-08-30 |
Gilead Sciences, Inc. |
Inhibitors of bruton's tyrosine kinase
|
|
WO2018157277A1
(en)
*
|
2017-02-28 |
2018-09-07 |
Eli Lilly And Company |
Isoquinolin and naphthydrin compounds
|
|
CN115504986B
(zh)
*
|
2017-03-03 |
2024-05-14 |
江苏豪森药业集团有限公司 |
凋亡信号调节激酶抑制剂及其制备方法和应用
|
|
WO2018169742A1
(en)
|
2017-03-14 |
2018-09-20 |
Gilead Sciences, Inc. |
Apoptosis signal-regulating kinase inhibtor
|
|
WO2018183342A1
(en)
|
2017-03-28 |
2018-10-04 |
Gilead Sciences, Inc. |
Methods of treating liver disease
|
|
AU2018250614A1
(en)
|
2017-04-12 |
2019-10-17 |
Gilead Sciences, Inc. |
Methods of treating liver disease
|
|
BR102018007822A2
(pt)
|
2017-04-20 |
2018-11-06 |
Gilead Sciences, Inc. |
composto, métodos para inibir pd-1, pd-l1 e/ou interação de pd-1/pd-l1 e para tratamento de câncer, composição farmacêutica, e, kit para tratamento de ou prevenção de câncer ou uma doença ou condição
|
|
CN110869017B
(zh)
|
2017-05-12 |
2023-05-05 |
英安塔制药有限公司 |
细胞凋亡信号调节激酶1抑制剂及其使用方法
|
|
WO2018218051A1
(en)
*
|
2017-05-25 |
2018-11-29 |
Enanta Pharmaceuticals, Inc. |
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
|
|
WO2018218044A2
(en)
*
|
2017-05-25 |
2018-11-29 |
Enanta Pharmaceuticals Inc |
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
|
|
US10253018B2
(en)
|
2017-05-25 |
2019-04-09 |
Enanta Pharmaceuticals, Inc. |
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
|
|
WO2018231851A1
(en)
|
2017-06-13 |
2018-12-20 |
Gilead Sciences, Inc. |
Methods of treating liver fibrosis
|
|
CN109265443B
(zh)
*
|
2017-07-18 |
2022-11-29 |
南京圣和药业股份有限公司 |
作为ask抑制剂的杂环化合物及其应用
|
|
WO2019046186A1
(en)
|
2017-08-28 |
2019-03-07 |
Enanta Pharmaceuticals, Inc. |
INHIBITORS OF KINASE 1 REGULATING THE APOPTOTIC SIGNAL CONTAINING TETRAZOLES AND METHODS OF USE THEREOF
|
|
CN109456308B
(zh)
*
|
2017-09-06 |
2022-11-29 |
南京圣和药业股份有限公司 |
作为ask抑制剂的杂环化合物及其应用
|
|
WO2019047094A1
(en)
*
|
2017-09-07 |
2019-03-14 |
Eli Lilly And Company |
CYCLOBUTYL-IMIDAZOLIDINONE COMPOUNDS
|
|
US10370352B2
(en)
|
2017-09-07 |
2019-08-06 |
Eli Lilly And Company |
Cyclobutyl-imidazolidinone compounds
|
|
CN111315380A
(zh)
|
2017-09-08 |
2020-06-19 |
弗朗塞拉美国制药有限责任公司 |
凋亡信号调节激酶抑制剂及其用途
|
|
WO2019047161A1
(en)
|
2017-09-08 |
2019-03-14 |
Eli Lilly And Company |
IMIDAZOLIDINE COMPOUNDS
|
|
CN111518080A
(zh)
*
|
2017-10-12 |
2020-08-11 |
深圳市塔吉瑞生物医药有限公司 |
一种1,2,4-三氮唑类化合物
|
|
CN107793400B
(zh)
*
|
2017-10-31 |
2020-01-31 |
武汉九州钰民医药科技有限公司 |
吡啶类化合物及其在制备治疗肝脏疾病的药物中的应用
|
|
ES2986647T3
(es)
|
2017-11-13 |
2024-11-12 |
Gilead Sciences Inc |
Método de estadificación de la fibrosis hepática en pacientes con EHNA
|
|
CN111511754B
(zh)
|
2017-12-20 |
2023-09-12 |
捷克共和国有机化学与生物化学研究所 |
活化sting转接蛋白的具有膦酸酯键的2’3’环状二核苷酸
|
|
US10966999B2
(en)
|
2017-12-20 |
2021-04-06 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
3′3′ cyclic dinucleotides with phosphonate bond activating the sting adaptor protein
|
|
CN111801314B
(zh)
|
2018-01-02 |
2023-10-31 |
西尔洛克治疗公司 |
Ask1抑制剂化合物及其用途
|
|
TWI707849B
(zh)
|
2018-02-13 |
2020-10-21 |
美商基利科學股份有限公司 |
Pd‐1/pd‐l1抑制劑
|
|
CN110294742B
(zh)
*
|
2018-03-21 |
2023-01-31 |
山东轩竹医药科技有限公司 |
并环类ask1抑制剂及其应用
|
|
TW202005654A
(zh)
|
2018-04-06 |
2020-02-01 |
捷克科學院有機化學與生物化學研究所 |
２，２，─環二核苷酸
|
|
TWI833744B
(zh)
|
2018-04-06 |
2024-03-01 |
捷克科學院有機化學與生物化學研究所 |
3'3'-環二核苷酸
|
|
TWI818007B
(zh)
|
2018-04-06 |
2023-10-11 |
捷克科學院有機化學與生物化學研究所 |
2'3'-環二核苷酸
|
|
US10919911B2
(en)
|
2018-04-12 |
2021-02-16 |
Terns, Inc. |
Tricyclic ASK1 inhibitors
|
|
KR102591947B1
(ko)
|
2018-04-19 |
2023-10-25 |
길리애드 사이언시즈, 인코포레이티드 |
Pd-1/pd-l1 억제제
|
|
CN110407806B
(zh)
*
|
2018-04-28 |
2021-08-17 |
深圳微芯生物科技股份有限公司 |
甲酰胺类化合物、其制备方法及其应用
|
|
EP3787621B1
(en)
|
2018-05-02 |
2024-12-18 |
Enanta Pharmaceuticals, Inc. |
Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
|
|
WO2019213239A1
(en)
|
2018-05-02 |
2019-11-07 |
Enanta Pharmaceuticals Inc. |
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
|
|
WO2019211799A1
(en)
|
2018-05-03 |
2019-11-07 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
2'3'-cyclic dinucleotide analogue comprising a cyclopentanyl modified nucleotide
|
|
JP2021523151A
(ja)
|
2018-05-11 |
2021-09-02 |
ホスホレックス、インコーポレイテッド |
負の表面電荷を有するマイクロ粒子及びナノ粒子
|
|
EP3793565B1
(en)
|
2018-05-14 |
2022-01-05 |
Gilead Sciences, Inc. |
Mcl-1 inhibitors
|
|
WO2020006429A1
(en)
*
|
2018-06-28 |
2020-01-02 |
Hepatikos Therapeutics, Llc |
Ask1 isoindolin-1-one inhibitors and methods of use thereof
|
|
EP3820572B1
(en)
|
2018-07-13 |
2023-08-16 |
Gilead Sciences, Inc. |
Pd-1/pd-l1 inhibitors
|
|
CN112638912B
(zh)
*
|
2018-07-20 |
2022-04-26 |
福建广生中霖生物科技有限公司 |
作为ask1抑制剂的晶型及其制备方法和应用
|
|
US10968199B2
(en)
|
2018-08-22 |
2021-04-06 |
Enanta Pharmaceuticals, Inc. |
Cycloalkyl-containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
|
|
WO2020072656A1
(en)
|
2018-10-03 |
2020-04-09 |
Gilead Sciences, Inc. |
Imidozopyrimidine derivatives
|
|
KR102298546B1
(ko)
|
2018-10-18 |
2021-09-08 |
에이치케이이노엔 주식회사 |
신규한 n-(이소프로필-트리아졸릴)피리디닐)-헤테로아릴-카르복사미드 유도체 및 이의 용도
|
|
US11236085B2
(en)
|
2018-10-24 |
2022-02-01 |
Gilead Sciences, Inc. |
PD-1/PD-L1 inhibitors
|
|
TWI721623B
(zh)
|
2018-10-31 |
2021-03-11 |
美商基利科學股份有限公司 |
經取代之6-氮雜苯并咪唑化合物
|
|
TW202136261A
(zh)
|
2018-10-31 |
2021-10-01 |
美商基利科學股份有限公司 |
經取代之6-氮雜苯并咪唑化合物
|
|
CN111170995A
(zh)
*
|
2018-11-09 |
2020-05-19 |
山东轩竹医药科技有限公司 |
Ask1抑制剂及其应用
|
|
WO2020106707A1
(en)
|
2018-11-19 |
2020-05-28 |
Enanta Pharmaceuticals, Inc. |
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
|
|
CN109608441A
(zh)
*
|
2018-12-26 |
2019-04-12 |
都创(上海)医药科技有限公司 |
一种ask1抑制剂的合成工艺
|
|
EP3911647B1
(en)
|
2019-01-15 |
2023-12-13 |
Gilead Sciences, Inc. |
Isoxazole compound as fxr agonist and pharmaceutical compositions comprising same
|
|
CN109813915A
(zh)
*
|
2019-02-15 |
2019-05-28 |
浠思（上海）生物技术有限公司 |
利用htrf一步法筛选激酶抑制剂的方法
|
|
CA3233305A1
(en)
|
2019-02-19 |
2020-08-27 |
Gilead Sciences, Inc. |
Solid forms of fxr agonists
|
|
KR102707808B1
(ko)
|
2019-03-07 |
2024-09-19 |
인스티튜트 오브 오가닉 케미스트리 앤드 바이오케미스트리 에이에스 씨알 브이.브이.아이. |
2'3'-사이클릭 다이뉴클레오티드 및 이의 프로드럭
|
|
US11766447B2
(en)
|
2019-03-07 |
2023-09-26 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
3′3′-cyclic dinucleotide analogue comprising a cyclopentanyl modified nucleotide as sting modulator
|
|
EP3935066A1
(en)
|
2019-03-07 |
2022-01-12 |
Institute of Organic Chemistry and Biochemistry ASCR, V.V.I. |
3'3'-cyclic dinucleotides and prodrugs thereof
|
|
AU2020234929B2
(en)
|
2019-03-11 |
2023-09-14 |
Gilead Sciences, Inc. |
Formulations of a compound and uses thereof
|
|
US11466033B2
(en)
|
2019-03-25 |
2022-10-11 |
Enanta Pharmaceuticals, Inc. |
Substituted pyridines as apoptosis signal-regulating kinase 1 inhibitors
|
|
TW202210480A
(zh)
|
2019-04-17 |
2022-03-16 |
美商基利科學股份有限公司 |
類鐸受體調節劑之固體形式
|
|
TW202212339A
(zh)
|
2019-04-17 |
2022-04-01 |
美商基利科學股份有限公司 |
類鐸受體調節劑之固體形式
|
|
US11453681B2
(en)
|
2019-05-23 |
2022-09-27 |
Gilead Sciences, Inc. |
Substituted eneoxindoles and uses thereof
|
|
TWI770527B
(zh)
|
2019-06-14 |
2022-07-11 |
美商基利科學股份有限公司 |
Cot 調節劑及其使用方法
|
|
US20220305115A1
(en)
|
2019-06-18 |
2022-09-29 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and pyridopyrimidine derivatives
|
|
CR20210687A
(es)
|
2019-06-25 |
2022-03-03 |
Gilead Sciences Inc |
PROTEÍNAS DE FUSIÓN FLT3L-Fc Y MÉTODOS DE USO
|
|
US20220332700A1
(en)
*
|
2019-06-26 |
2022-10-20 |
Mankind Pharma Ltd |
Novel apoptosis signal-regulating kinase 1 inhibitors
|
|
AR119594A1
(es)
|
2019-08-09 |
2021-12-29 |
Gilead Sciences Inc |
Derivados de tienopirimidina como inhibidores acc y usos de los mismos
|
|
CN114555123B
(zh)
|
2019-10-18 |
2024-04-02 |
四十七公司 |
用于治疗骨髓增生异常综合征和急性髓系白血病的联合疗法
|
|
KR20220091576A
(ko)
|
2019-10-31 |
2022-06-30 |
포티 세븐, 인코포레이티드 |
혈액암의 항-cd47 및 항-cd20 기반 치료
|
|
TWI778443B
(zh)
|
2019-11-12 |
2022-09-21 |
美商基利科學股份有限公司 |
Mcl1抑制劑
|
|
AU2020384883B2
(en)
|
2019-11-15 |
2023-11-16 |
Gilead Sciences, Inc. |
Triazole carbamate pyridyl sulfonamides as LPA receptor antagonists and uses thereof
|
|
CN111018831B
(zh)
*
|
2019-11-21 |
2022-05-31 |
中国药科大学 |
细胞凋亡信号调节激酶抑制剂及其应用
|
|
US20230105984A1
(en)
|
2019-12-23 |
2023-04-06 |
Svetlana Marukian |
Compositions and methods for the treatment of liver diseases and disorders
|
|
LT4081305T
(lt)
|
2019-12-24 |
2024-11-25 |
Carna Biosciences, Inc. |
Diacilglicerolio kinazę moduliuojantys junginiai
|
|
KR20260017503A
(ko)
|
2020-02-14 |
2026-02-05 |
길리애드 사이언시즈, 인코포레이티드 |
Ccr8에 결합하는 항체 및 융합 단백질, 및 이의 용도
|
|
AU2021249010B2
(en)
|
2020-03-30 |
2024-09-26 |
Gilead Sciences, Inc. |
Solid forms of (S)-6-(((1-(bicyclo[1.1.1]pentan-1-yl)-1H-1,2,3-triazol-4-yl)2-methyl-1-oxo-1,2- dihydroisoquinolin-5-yl)methyl)))amino)8-chloro-(neopentylamino)quinoline-3-carb onitrile a cot inhibitor compound
|
|
JP7446475B2
(ja)
|
2020-04-02 |
2024-03-08 |
ギリアード サイエンシーズ， インコーポレイテッド |
Ｃｏｔ阻害剤化合物を調製するためのプロセス
|
|
JP7564888B2
(ja)
|
2020-05-01 |
2024-10-09 |
ギリアード サイエンシーズ， インコーポレイテッド |
Ｃｄ７３阻害性２，４－ジオキソピリミジン化合物
|
|
CN115867556B
(zh)
|
2020-06-03 |
2025-05-06 |
吉利德科学公司 |
Lpa受体拮抗剂及其用途
|
|
CN113831323B
(zh)
*
|
2020-06-24 |
2025-08-29 |
武汉人福创新药物研发中心有限公司 |
芳杂环酰胺类化合物及其用途
|
|
CN111808079A
(zh)
*
|
2020-08-05 |
2020-10-23 |
中国药科大学 |
吲哚类ask1小分子抑制剂及其制备方法和应用
|
|
CN114470217B
(zh)
*
|
2020-11-24 |
2023-06-20 |
深圳微芯生物科技股份有限公司 |
预防和治疗代谢异常或炎症引起的组织损伤的药物组合物
|
|
EP4304711A1
(en)
|
2021-03-11 |
2024-01-17 |
Gilead Sciences, Inc. |
Glp-1r modulating compounds
|
|
CA3214961A1
(en)
|
2021-03-29 |
2022-10-06 |
Gilead Sciences, Inc. |
Khk inhibitors
|
|
TW202302145A
(zh)
|
2021-04-14 |
2023-01-16 |
美商基利科學股份有限公司 |
ＣＤ４７／ＳＩＲＰα結合及ＮＥＤＤ８活化酶Ｅ１調節次單元之共抑制以用於治療癌症
|
|
CN114246866B
(zh)
*
|
2021-04-28 |
2023-09-12 |
深圳微芯生物科技股份有限公司 |
用于治疗慢性肾病的药物及其用途
|
|
TWI853704B
(zh)
|
2021-05-11 |
2024-08-21 |
美商基利科學股份有限公司 |
Lpa受體拮抗劑及其用途
|
|
KR20240007233A
(ko)
|
2021-05-13 |
2024-01-16 |
길리애드 사이언시즈, 인코포레이티드 |
Lpa 수용체 길항제 및 이의 용도
|
|
TW202313094A
(zh)
|
2021-05-18 |
2023-04-01 |
美商基利科學股份有限公司 |
使用ＦＬＴ３Ｌ—Ｆｃ融合蛋白之方法
|
|
TW202304435A
(zh)
|
2021-06-04 |
2023-02-01 |
美商基利科學股份有限公司 |
治療ｎａｓｈ之方法
|
|
TW202311256A
(zh)
|
2021-06-18 |
2023-03-16 |
美商基利科學股份有限公司 |
用於治療ｆｘｒ誘發之搔癢之ｉｌ－３１調節劑
|
|
KR20240005901A
(ko)
|
2021-06-23 |
2024-01-12 |
길리애드 사이언시즈, 인코포레이티드 |
디아실글리세롤 키나제 조절 화합물
|
|
CA3222277A1
(en)
|
2021-06-23 |
2022-12-29 |
Gilead Sciences, Inc. |
Diacylglyercol kinase modulating compounds
|
|
WO2022271677A1
(en)
|
2021-06-23 |
2022-12-29 |
Gilead Sciences, Inc. |
Diacylglyercol kinase modulating compounds
|
|
WO2022271659A1
(en)
|
2021-06-23 |
2022-12-29 |
Gilead Sciences, Inc. |
Diacylglyercol kinase modulating compounds
|
|
US20230183216A1
(en)
|
2021-10-28 |
2023-06-15 |
Gilead Sciences, Inc. |
Pyridizin-3(2h)-one derivatives
|
|
EP4422756A1
(en)
|
2021-10-29 |
2024-09-04 |
Gilead Sciences, Inc. |
Cd73 compounds
|
|
WO2023107954A1
(en)
|
2021-12-08 |
2023-06-15 |
Dragonfly Therapeutics, Inc. |
Antibodies targeting 5t4 and uses thereof
|
|
US20230203202A1
(en)
|
2021-12-08 |
2023-06-29 |
Dragonfly Therapeutics, Inc. |
Proteins binding nkg2d, cd16 and 5t4
|
|
WO2023107938A1
(en)
|
2021-12-08 |
2023-06-15 |
Gilead Sciences, Inc. |
Lpa receptor antagonists and uses thereof
|
|
CN118488946A
(zh)
|
2021-12-22 |
2024-08-13 |
吉利德科学公司 |
Ikaros锌指家族降解剂及其用途
|
|
EP4452415B1
(en)
|
2021-12-22 |
2026-02-25 |
Gilead Sciences, Inc. |
Ikaros zinc finger family degraders and uses thereof
|
|
TW202340168A
(zh)
|
2022-01-28 |
2023-10-16 |
美商基利科學股份有限公司 |
Ｐａｒｐ７抑制劑
|
|
CA3253296A1
(en)
|
2022-03-17 |
2023-09-21 |
Gilead Sciences, Inc. |
Zinc Finger Degradation Agents of the Ikaros Family and Their Uses
|
|
AU2023240346A1
(en)
|
2022-03-24 |
2024-09-19 |
Gilead Sciences, Inc. |
Combination therapy for treating trop-2 expressing cancers
|
|
TWI876305B
(zh)
|
2022-04-05 |
2025-03-11 |
美商基利科學股份有限公司 |
用於治療結腸直腸癌之組合療法
|
|
WO2023205719A1
(en)
|
2022-04-21 |
2023-10-26 |
Gilead Sciences, Inc. |
Kras g12d modulating compounds
|
|
US20240116928A1
(en)
|
2022-07-01 |
2024-04-11 |
Gilead Sciences, Inc. |
Cd73 compounds
|
|
WO2024064668A1
(en)
|
2022-09-21 |
2024-03-28 |
Gilead Sciences, Inc. |
FOCAL IONIZING RADIATION AND CD47/SIRPα DISRUPTION ANTICANCER COMBINATION THERAPY
|
|
EP4638436A1
(en)
|
2022-12-22 |
2025-10-29 |
Gilead Sciences, Inc. |
Prmt5 inhibitors and uses thereof
|
|
CN115844887B
(zh)
*
|
2022-12-28 |
2023-09-08 |
中国人民解放军空军军医大学 |
Selonsertib在制备治疗癌症的药物中的用途
|
|
CN120882725A
(zh)
|
2023-04-11 |
2025-10-31 |
吉利德科学公司 |
Kras调节化合物
|
|
WO2024220917A1
(en)
|
2023-04-21 |
2024-10-24 |
Gilead Sciences, Inc. |
Prmt5 inhibitors and uses thereof
|
|
EP4713321A1
(en)
*
|
2023-05-18 |
2026-03-25 |
Council of Scientific and Industrial Research |
Protacs for ask1 protein degradation: preparation and use thereof
|
|
US20250042922A1
(en)
|
2023-06-30 |
2025-02-06 |
Gilead Sciences, Inc. |
Kras modulating compounds
|
|
WO2025014332A1
(ko)
|
2023-07-12 |
2025-01-16 |
한국화학연구원 |
신규한 고리 구조의 트리아졸 화합물, 이의 제조방법 및 이의 용도
|
|
AU2024297978A1
(en)
|
2023-07-26 |
2026-02-05 |
Gilead Sciences, Inc. |
Parp7 inhibitors
|
|
US20250066328A1
(en)
|
2023-07-26 |
2025-02-27 |
Gilead Sciences, Inc. |
Parp7 inhibitors
|
|
AU2024337913A1
(en)
|
2023-09-08 |
2026-03-26 |
Gilead Sciences, Inc. |
Pyrimidine-containing polycyclic derivatives as kras g12d modulating compounds
|
|
WO2025054347A1
(en)
|
2023-09-08 |
2025-03-13 |
Gilead Sciences, Inc. |
Kras g12d modulating compounds
|
|
US20250154172A1
(en)
|
2023-11-03 |
2025-05-15 |
Gilead Sciences, Inc. |
Prmt5 inhibitors and uses thereof
|
|
WO2025137640A1
(en)
|
2023-12-22 |
2025-06-26 |
Gilead Sciences, Inc. |
Azaspiro wrn inhibitors
|
|
US20250376484A1
(en)
|
2024-05-21 |
2025-12-11 |
Gilead Sciences, Inc. |
Prmt5 inhibitors and uses thereof
|
|
WO2026039365A1
(en)
|
2024-08-12 |
2026-02-19 |
Gilead Sciences, Inc. |
Kras modulating compounds
|